Cite
HARVARD Citation
Rodriguez-Otero, P. et al. (n.d.). B04: COMBINATION OF SUBCUTANEOUS TECLISTAMAB WITH DARATUMUMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): RESULTS FROM A PHASE 1B MULTICOHORT STUDY. HemaSphere. pp. 7-8. [Online].